Prot #ADS-AMT-PD304: ADS-5102(Amantadine HCL) Extended Release Efficacy and Safety Study in Parkinson's Disease Patients with Levopa-Induced Dyskinesia

Project: Research project

Project Details

StatusFinished
Effective start/end date7/23/157/23/18

Funding

  • Adamas Pharmaceuticals, Inc. (Prot #ADS-AMT-PD304)